Patient involvement in the development of drugs for rare diseases.
The landscape of RWD can be difficult to navigate. Learn more in this recent webinar recording.
Keeping your clinical trial on track in an evolving environment.
Transforming recruitment through patient-centric trials and real-world, real-time data.
ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.
From recruitment of a single clinical professional to managing entire global functions.
ICON can support product design, development and registration, regulatory support and commercialisation of Biosimilars.
FIRECREST: Digital solutions to increase efficiency in clinical trials by driving site performance.
The COVID-19 pandemic has not only impacted access to healthcare, but also significantly disrupted the conduct of clinical trials investigating therapies intended to treat cardiovascular (CV) diseases.